A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Clinical trial NCT05514327 · RECRUITING

Trial details

NCT number: NCT05514327
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma CAR-T Radiotherapy Bridging Therapy

Start date: 2022-09-01
Primary completion: 2027-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.